Mga Batayang Estadistika
| LEI | 54930069VDTITHOTKJ98 |
| CIK | 1027838 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Tactile Systems Technology, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 4, 2025 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| August 4, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 Ta |
|
| August 4, 2025 |
Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results Exhibit 99.1 Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results MINNEAPOLIS, MN, August 4, 2025 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Summary & |
|
| August 4, 2025 |
Exhibit 10.5 EXECUTION VERSION $40,000,000 AMENDED AND RESTATED CREDIT AGREEMENT dated as of July 31, 2025, by and among Tactile Systems Technology, Inc. dba Tactile Medical, as Borrower, the Lenders referred to herein, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent and Swingline Lender TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 SECTION 1.1 Definitions 1 SECTIO |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Tactile Systems Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 3701 Wayzata Blvd, Suite 300 Minneapolis, Minnesota 55416 (Addr |
|
| May 9, 2025 |
Tactile Systems Technology, Inc. 2025 Equity Incentive Plan Exhibit 10.1 TACTILE SYSTEMS TECHNOLOGY, INC. 2025 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the Tactile Systems Technology, Inc. 2025 Equity Incentive Plan (the “Plan”), is to attract, retain and motivate the best available service providers for positions of responsibility with the Company, to provide additional equity incentives to them that are intended to align their interest |
|
| May 9, 2025 |
Exhibit 10.3 $CurrentDate$/ TACTILE SYSTEMS TECHNOLOGY, INC. 2025 EQUITY INCENTIVE PLAN Restricted Stock Unit Award Agreement (Director) Tactile Systems Technology, Inc. (the “Company”), pursuant to its 2025 Equity Incentive Plan (the “Plan”), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricte |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (IRS Empl |
|
| May 9, 2025 |
Form of Restricted Stock Unit Award Agreement (Executives) under the 2025 Equity Incentive Plan Exhibit 10.2 TACTILE SYSTEMS TECHNOLOGY, INC. 2025 EQUITY INCENTIVE PLAN Restricted Stock Unit Award Agreement Tactile Systems Technology, Inc. (the “Company”), pursuant to its 2025 Equity Incentive Plan (the “Plan”), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreeme |
|
| May 9, 2025 |
Form of Performance Stock Unit Agreement under the 2025 Equity Incentive Plan Exhibit 10.4 TACTILE SYSTEMS TECHNOLOGY, INC. 2025 EQUITY INCENTIVE PLAN Performance Stock Unit Agreement Tactile Systems Technology, Inc. (the “Company”), pursuant to its 2025 Equity Incentive Plan (the “Plan”), hereby grants an award of Performance Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Performance Stock Unit Agreement (the “ |
|
| May 7, 2025 |
Exhibit 107 Calculation of Registration Fee FORM S-8 (Form Type) TACTILE SYSTEMS TECHNOLOGY, INC. |
|
| May 7, 2025 |
As filed with the Securities and Exchange Commission on May 7, 2025 As filed with the Securities and Exchange Commission on May 7, 2025 Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 5, 2025 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. Em |
|
| May 5, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 T |
|
| May 5, 2025 |
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results Exhibit 99.1 Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results MINNEAPOLIS, MN, May 5, 2025 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Summary & Rece |
|
| March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ◻ Defin |
|
| March 28, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| February 18, 2025 |
TACTILE SYSTEMS TECHNOLOGY, INC. REQUIRED COMPENSATION RECOVERY POLICY (Effective 02 October 2023) TACTILE SYSTEMS TECHNOLOGY, INC. REQUIRED COMPENSATION RECOVERY POLICY (Effective 02 October 2023) Policy The Board of Directors (the “Board”) of Tactile System Technology, Inc. (the “Company”) has adopted this Required Compensation Recovery Policy (this “Policy”) pursuant to Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Securities and Exchange Commission |
|
| February 18, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 18, 2025 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| February 18, 2025 |
As filed with the Securities and Exchange Commission on February 18, 2025 S-8 1 tm256777d1s8.htm FORM S-8 As filed with the Securities and Exchange Commission on February 18, 2025 Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 41-180 |
|
| February 18, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-3779 |
|
| February 18, 2025 |
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results Exhibit 99.1 Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results MINNEAPOLIS, MN, February 18, 2025 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, |
|
| February 18, 2025 |
Non-Employee Director Compensation Policy TACTILE SYSTEMS TECHNOLOGY, INC. Non-Employee Director Compensation Summary Adopted: 05 December 2024 Effective: Immediately prior to 2025 Annual Meeting of Stockholders Each non-management director of Tactile Systems Technology, Inc. (the “Company”) will receive: Director annual retainer: Annual retainer, payable in cash, of $50,000 per director except for the chairperson who shall receive $100,0 |
|
| February 18, 2025 |
Exhibit 107 Calculation of Registration Fee FORM S-8 (Form Type) TACTILE SYSTEMS TECHNOLOGY, INC. |
|
| February 18, 2025 |
Tactile Systems Technology, Inc. Insider Trading Policy TACTILE SYSTEMS TECHNOLOGY, INC. Insider Trading Policy Amended: February 13, 2025 Federal and state securities laws prohibit individuals from trading in the securities of a company while they are aware of material information about that company that is not generally known or available to the public. Such trading is often referred to as “insider trading.” The purpose of this Insider Trading Policy |
|
| January 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 10, 2025 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R. |
|
| January 13, 2025 |
Tactile Medical Appoints Laura King to Board of Directors EX-99.1 2 tm253038d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Tactile Medical Appoints Laura King to Board of Directors MINNEAPOLIS, January 13, 2025 - (GLOBE NEWSWIRE) - Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company’s Board of Directors |
|
| November 13, 2024 |
TCMD / Tactile Systems Technology, Inc. / CADIAN CAPITAL MANAGEMENT, LP Passive Investment SC 13G/A 1 formsc13ga-tactile.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 87357P100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) |
|
| November 4, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 4, 2024 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R. |
|
| November 4, 2024 |
Tactile Systems Technology, Inc. EXECUTIVE EMPLOYEE SEVERANCE PLAN Adopted: 01-Nov-2018 Amended and Restated: 15-Oct-2024 I.INTRODUCTION Tactile Systems Technology, Inc. (the “Company”) has established the Tactile Systems Technology, Inc. Executive Employee Severance Plan (the “Plan”) to provide severance pay and other benefits to eligible executive-level employees of the Company whose employment |
|
| November 4, 2024 |
Exhibit 99.1 Tactile Systems Technology, Inc. Reports Third Quarter 2024 Financial Results Authorizes Share Repurchase Program MINNEAPOLIS, MN, November 4, 2024 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended Septembe |
|
| November 4, 2024 |
Exhibit 10.2 Execution Copy FIFTH AMENDMENT AGREEMENT This FIFTH AMENDMENT AGREEMENT (this “Amendment”), dated as of November 1, 2024, is entered into among Tactile Systems Technology, Inc., a Delaware corporation (dba Tactile Medical) (the “Borrower”), the Lenders (as defined below) signatory hereto, and Wells Fargo Bank, National Association, a national banking association, as administrative age |
|
| November 4, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-377 |
|
| August 5, 2024 |
Exhibit 10.4 June 20, 2024 Daniel Reuvers (By E-Mail) Dear Dan, As a supplement to that certain letter agreement, between you and Tactile Systems Technology, Inc. dated April 23, 2024 (the “Letter”), we wish to clarify the provision titled “Your Equity Rights”. For the avoidance of doubt, we confirm that, unless otherwise modified by separate written agreement between you and the Company, the date |
|
| August 5, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 5, 2024 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| August 5, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 Ta |
|
| August 5, 2024 |
Tactile Systems Technology, Inc. Reports Second Quarter 2024 Financial Results Exhibit 99.1 Tactile Systems Technology, Inc. Reports Second Quarter 2024 Financial Results MINNEAPOLIS, MN, August 5, 2024 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlight |
|
| August 5, 2024 |
Exhibit 3.3 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TACTILE SYSTEMS TECHNOLOGY, INC. (Conformed Version Reflecting All Amendments Through May 8, 2024) ARTICLE 1 Name The name of the Corporation is Tactile Systems Technology, Inc. ARTICLE 2 Registered Office The address of the Corporation’s registered office in the State of Delaware is 2711 Centerville Road, Suite 400, Wilmington, Dela |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 2) Tactile Systems Technology, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 87357P100 (CUSIP Number) June 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 5, 2024 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. E |
|
| July 5, 2024 |
UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE Exhibit 99.2 UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE JACK WEAVER, Derivatively on Behalf of TACTILE SYSTEMS TECHNOLOGY, INC., Plaintiff, v. BRENT MOEN, et al., Defendants, -and- TACTILE SYSTEMS TECHNOLOGY, INC., Nominal Defendant. CASE NO. 1:22-cv-01063-GBW STIPULATION OF SETTLEMENT This Stipulation of Settlement, dated June 6, 2024 (the “Stipulation”), is made and entered into by and am |
|
| July 5, 2024 |
UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE Exhibit 99.1 UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE JACK WEAVER, Derivatively on Behalf of TACTILE SYSTEMS TECHNOLOGY, INC., Plaintiff, v. BRENT MOEN, et al., Defendants, -and- TACTILE SYSTEMS TECHNOLOGY, INC., Nominal Defendant. Case No. 1:22-cv-01063-GBW NOTICE OF PENDENCY OF DERIVATIVE ACTION, PROPOSED AGREEMENT OF SETTLEMENT AND RELEASE, AND SETTLEMENT HEARING TO: ALL CURRENT RECORD |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Tactile Systems Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37799 (State or other jurisdiction of incorporation) (Commission File Number) 3701 Wayzata Blvd, Suite 300 Minneapolis, Minnesota 55416 (Address of principal executive offices) (Zip Code) E |
|
| May 9, 2024 |
Certificate of Amendment to Amended and Restated Certificate of Incorporation, dated May 8, 2024 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF TACTILE SYSTEMS TECHNOLOGY, INC. Tactile Systems Technology, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), hereby certifies as follows: FIRST: At a meeting of the Board of Directors of the Corporation, the Board of Directors approved a proposed am |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2024 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (IRS Empl |
|
| May 6, 2024 |
Exhibit 99.1 Tactile Systems Technology, Inc. Reports First Quarter 2024 Financial Results Reaffirms Full Year 2024 Outlook MINNEAPOLIS, MN, May 6, 2024 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2024. |
|
| May 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 6, 2024 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. Em |
|
| May 6, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 T |
|
| April 23, 2024 |
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue Exhibit 99.1 Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue · CEO Dan Reuvers to retire; Healthcare veteran and board director Sheri Dodd appointed as Chief Executive Officer · Preliminary, unaudited total revenue for first quarter of 2024 expected to be approximately $61 million · Management to host conference call on May 6, 2024 to discuss first quarter 2024 |
|
| April 23, 2024 |
Form of Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement Exhibit 10.2 TACTILE SYSTEMS TECHNOLOGY, INC. Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement This Confidentiality, Assignment of Intellectual Property and Restrictive Covenants Agreement (together with Exhibit A and Exhibit B, this “Agreement”), entered into effective [], 20[] (the “Effective Date”), is intended to formalize in writing certain understandin |
|
| April 23, 2024 |
Exhibit 10.4 April 23, 2024 Daniel Reuvers (By E-mail) Dear Dan: Thank you again for your thoughtful approach to your retirement from Tactile Systems Technology, Inc. (the “Company”). On behalf of the Company’s entire Board of Directors (the “Board”), I extend the Board’s sincere appreciation for your years of dedicated service to the Company and for working with the Board to develop a smooth tran |
|
| April 23, 2024 |
Offer Letter between Sheri L. Dodd and Tactile Systems Technology, Inc., dated April 23, 2024 Exhibit 10.1 April 23, 2024 Sheri Dodd (By E-mail) Dear Sheri: We are pleased to offer you the full-time position as Chief Executive Officer at Tactile Systems Technology, Inc. (the “Company”). Your employment start date is June 30, 2024, and you will become the Company’s Chief Executive Officer and Assistant Secretary effective July 1, 2024. This employment offer is conditioned on you countersign |
|
| April 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| April 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 23, 2024 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ◻ Defin |
|
| March 27, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 15, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant ◻ Check the appropriate box: þ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| February 20, 2024 |
Tactile Systems Technology, Inc. Required Compensation Recovery Policy TACTILE SYSTEMS TECHNOLOGY, INC. REQUIRED COMPENSATION RECOVERY POLICY (Effective 02 October 2023) Policy The Board of Directors (the “Board”) of Tactile System Technology, Inc. (the “Company”) has adopted this Required Compensation Recovery Policy (this “Policy”) pursuant to Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Securities and Exchange Commission |
|
| February 20, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-3779 |
|
| February 20, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 20, 2024 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| February 20, 2024 |
As filed with the Securities and Exchange Commission on February 20, 2024 As filed with the Securities and Exchange Commission on February 20, 2024 Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 20, 2024 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 OUTLOOK Full Year Revenue Increased 11% Year-Over-Year; Full Year Net Income Increased 260%; Full Year Adjusted EBITDA Increased 62% MINNEAPOLIS, MN, February 20, 2024 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical tec |
|
| February 20, 2024 |
Exhibit 107 Calculation of Registration Fee FORM S-8 (Form Type) TACTILE SYSTEMS TECHNOLOGY, INC. |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2024 |
TCMD / Tactile Systems Technology, Inc. / CADIAN CAPITAL MANAGEMENT, LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 13, 2024 |
TCMD / Tactile Systems Technology, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv02032-tactilesystemstechno.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Tactile Systems Technology Inc Title of Class of Securities: Common Stock CUSIP Number: 87357P100 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate |
|
| November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 87357P100 (CUSIP Number) October 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| November 6, 2023 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS; UPDATES FULL YEAR 2023 OUTLOOK MINNEAPOLIS, MN, November 6, 2023 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30 |
|
| November 6, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 6, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R. |
|
| November 6, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-377 |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 2, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S |
|
| October 2, 2023 |
Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors Exhibit 99.1 Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors MINNEAPOLIS—October 2, 2023 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Vindell Washington, M.D. to the Company’s Board of Directors (“Board”), effectiv |
|
| August 7, 2023 |
Offer letter between Sherri Ferstler and Tactile Systems Technology, Inc., dated as of July 18, 2023 Exhibit 10.3 July 18, 2023 Sherri Ferstler [***] [***] Dear Sherri, We are pleased to offer you a full-time position as Senior Vice President Sales at Tactile Medical. Your start date is July 31, 2023. You will be a remote full-time exempt employee reporting to Dan Reuvers, Chief Executive Officer. Your starting salary will be $340,000 annually and will be paid bi-weekly. We are offering a sign-on |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 7, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| August 7, 2023 |
AMENDMENT TO ASSET PURCHASE AGREEMENT Exhibit 2.1 Execution Version AMENDMENT TO ASSET PURCHASE AGREEMENT This AMENDMENT TO ASSET PURCHASE AGREEMENT (this "Amendment") is entered into as of November 4, 2022 by and between Tactile Systems Technology, Inc., a Delaware corporation ("Buyer"), and Movair, Inc. (formerly known as International Biophysics Corporation), a Texas corporation ("Seller"), and amends that certain Asset Purchase Ag |
|
| August 7, 2023 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS; UPDATES FULL YEAR 2023 OUTLOOK MINNEAPOLIS, MN, August 7, 2023 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 202 |
|
| August 7, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 Ta |
|
| August 7, 2023 |
Exhibit 10.1 EXECUTION VERSION THIRD AMENDMENT AGREEMENT This THIRD AMENDMENT AGREEMENT (this “Amendment”), dated as of June 21, 2023, is entered into among Tactile Systems Technology, Inc., a Delaware corporation (dba Tactile Medical) (the “Borrower”), the Lenders (as defined below) signatory hereto, and Wells Fargo Bank, National Association, a national banking association, as administrative age |
|
| August 7, 2023 |
Exhibit 10.2 Execution Version FOURTH AMENDMENT AGREEMENT This FOURTH AMENDMENT AGREEMENT (this “Amendment”), dated as of August 1, 2023, is entered into among Tactile Systems Technology, Inc., a Delaware corporation (dba Tactile Medical) (the “Borrower”), the Lenders (as defined below) signatory hereto, and Wells Fargo Bank, National Association, a national banking association, as administrative |
|
| July 28, 2023 |
TCMD / Tactile Systems Technology Inc / Divisadero Street Capital Management, LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| July 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| July 18, 2023 |
Tactile Medical Appoints Sherri Ferstler as Senior Vice President of Sales Exhibit 99.1 Tactile Medical Appoints Sherri Ferstler as Senior Vice President of Sales MINNEAPOLIS—July 18, 2023 (GLOBE NEWSWIRE) —Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Sherri Ferstler to the position of Senior Vice President of Sales, effective Jul |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Tactile Systems Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37799 (State or other jurisdiction of incorporation) (Commission File Number) 3701 Wayzata Blvd, Suite 300 Minneapolis, Minnesota 55416 (Address of principal executive offices) (Zip Code) E |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (IRS Empl |
|
| May 8, 2023 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS; RAISES FULL YEAR 2023 OUTLOOK First Quarter Revenue Increased 23% Year-Over-Year MINNEAPOLIS, MN, May 8, 2023 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial res |
|
| May 8, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 T |
|
| May 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 8, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. Em |
|
| March 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ◻ Defin |
|
| March 27, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 14, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| March 14, 2023 |
Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer Exhibit 99.1 Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer MINNEAPOLIS, MN, March 14, 2023 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20 |
|
| March 14, 2023 |
Exhibit 10.1 February 21, 2023 Elaine Birkemeyer [***] [***] Dear Elaine, We are pleased to offer you a full-time position as Chief Financial Officer at Tactile Medical. Your start date is on or before March 2023. This employment offer is conditioned on the successful completion of a background check and on agreeing to abide by the terms set forth in the Employee Confidentiality Agreement. You wil |
|
| February 28, 2023 |
Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock Exhibit 99.1 Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock MINNEAPOLIS, Minn.—(GLOBE NEWSWIRE)—Feb. 23, 2023— Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today that it intends to offer an |
|
| February 28, 2023 |
Exhibit 1.1 UNDERWRITING AGREEMENT TACTILE SYSTEMS TECHNOLOGY, INC. 2,500,000 Shares of Common Stock Underwriting Agreement February 23, 2023 William Blair & Company, L.L.C. 150 North Riverside Plaza Chicago, Illinois 60606 Ladies and Gentlemen: Tactile Systems Technology, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to you, the underwriter listed in Schedule 1 hereto ( |
|
| February 28, 2023 |
Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock Exhibit 99.2 Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock MINNEAPOLIS, Minn.—(GLOBE NEWSWIRE)— Feb. 23, 2023— Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricin |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 23, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| February 27, 2023 |
2,500,000 Shares TACTILE SYSTEMS TECHNOLOGY, INC. Common Stock TABLE OF CONTENTS As filed pursuant to Rule 424(b)(5) Registration Statement No. |
|
| February 27, 2023 |
Exhibit 107 The prospectus supplement to which this Exhibit 107 is attached is a final prospectus supplement for the related offering. The maximum aggregate offering price for such offering is $37,375,000. |
|
| February 23, 2023 |
SUBJECT TO COMPLETION, DATED FEBRUARY 23, 2023 TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 20, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| February 21, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-3779 |
|
| February 21, 2023 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2023 OUTLOOK Fourth Quarter Revenue Increased 20% Year-Over-Year; Full Year Revenue Increased 19% Year-Over-Year MINNEAPOLIS, MN, February 21, 2023 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for |
|
| February 21, 2023 |
TACTILE SYSTEMS TECHNOLOGY, INC. ANNOUNCES CHIEF FINANCIAL OFFICER TO RETIRE IN 2023 Exhibit 99.2 TACTILE SYSTEMS TECHNOLOGY, INC. ANNOUNCES CHIEF FINANCIAL OFFICER TO RETIRE IN 2023 MINNEAPOLIS, MN, February 21, 2023 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that Brent Moen has communicated his intention to retire as Chief Financial Offic |
|
| February 21, 2023 |
Amended and Restated By-laws, effective December 19, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. AMENDED AND RESTATED BYLAWS Effective: December 19, 2022 Article I OFFICES Section 1.1REGISTERED OFFICE. The Corporation shall maintain a registered office and registered agent within the State of Delaware at such place within such State as may be designated from time to time by the board of directors of the Corporation. Section 1.2OTHER OFFICES. The Corporation ma |
|
| February 14, 2023 |
SC 13G/A 1 pt7213ga.htm SCHEDULE 13G/A, AMENDMENT #1 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* (Name of Issuer) Tactile Systems Technology, Inc. |
|
| February 9, 2023 |
TCMD / Tactile Systems Technology Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv02003-tactilesystemstechno.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Tactile Systems Technology Inc. Title of Class of Securities: Common Stock CUSIP Number: 87357P100 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriat |
|
| January 23, 2023 |
January 23, 2023 VIA EDGAR TRANSMISSION Division of Corporate Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| January 23, 2023 |
TCMD / Tactile Systems Technology Inc / MILLENNIUM MANAGEMENT LLC Passive Investment SC 13G/A 1 TCMDSC13GA2023.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) TACTILE SYSTEMS TECHNOLOGY, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 87357P100 (CUSIP Number) DECEMBER 31, 2022 (Date of event which requires filing of this statement) Chec |
|
| January 18, 2023 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) TACTILE SYSTEMS TECHNOLOGY, INC. |
|
| January 18, 2023 |
Exhibit 4.3 TACTILE SYSTEMS TECHNOLOGY, INC. TO [ ] Trustee INDENTURE Dated as of [ ] Senior Debt Securities Tactile Systems Technology, Inc. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of [ ] Trust Indenture Act Section Indenture Section §310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608, 610 §311(a) 613 (b) 613 §312(a) |
|
| January 18, 2023 |
As filed with the Securities and Exchange Commission on January 18, 2023 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 18, 2023 Registration No. |
|
| January 18, 2023 |
Form of Subordinated Indenture Exhibit 4.4 TACTILE SYSTEMS TECHNOLOGY, INC. TO [ ] Trustee INDENTURE Dated as of [ ] Subordinated Debt Securities Tactile Systems Technology, Inc. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of [ ] Trust Indenture Act Section Indenture Section §310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608, 610 §311(a) 613 |
|
| January 5, 2023 |
Tactile Medical Appoints Carmen Volkart to Board of Directors Exhibit 99.1 Tactile Medical Appoints Carmen Volkart to Board of Directors MINNEAPOLIS?January 5, 2023 (GLOBE NEWSWIRE) ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Carmen Volkart to the Company?s Board of Directors (?Board?), effective January 5, 2023. ? |
|
| January 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 5, 2023 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S |
|
| December 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 19, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| December 23, 2022 |
Exhibit 3.1 TACTILE SYSTEMS TECHNOLOGY, INC. AMENDED AND RESTATED BY - LAWS Effective: March 10, 2021 December 19, 2022 Article I OFFICES Section 1.1?????????????REGISTERED OFFICE. The Corporation shall maintain a registered office and registered agent within the State of Delaware at such place within such State as may be designated from time to time by the B board of D directors of the Corporatio |
|
| November 29, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 29, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| November 29, 2022 |
Exhibit 99.1 November 2022Investor PresentationNASDAQ: TCMD TACTILE MEDICAL | 2Thispresentationcontainsforward-lookingstatements.Forward-lookingstatementsaregenerallyidentifiablebytheuseofwordslike?may,??will,??should,??could,??expect,??anticipate,??estimate,??believe,??intend,??continue,??confident,??outlook,??guidance,??project,??goals,??lookforward,??poised,??designed,??plan,??return,??focused, |
|
| November 7, 2022 |
Exhibit 2.1 Execution Version AMENDMENT TO ASSET PURCHASE AGREEMENT This AMENDMENT TO ASSET PURCHASE AGREEMENT (this "Amendment") is entered into as of November 4, 2022 by and between Tactile Systems Technology, Inc., a Delaware corporation ("Buyer"), and Movair, Inc. (formerly known as International Biophysics Corporation), a Texas corporation ("Seller"), and amends that certain Asset Purchase Ag |
|
| November 7, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 7, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I. |
|
| November 7, 2022 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS; RAISES FULL YEAR 2022 OUTLOOK Third Quarter Revenue Increased 24% Year-Over-Year; First Nine Months Revenue Increased 18% Year-Over-Year MINNEAPOLIS, MN, November 7, 2022 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices |
|
| November 7, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-377 |
|
| August 1, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 Ta |
|
| August 1, 2022 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS; RAISES FULL YEAR 2022 OUTLOOK Second Quarter Revenue Increased 17% Year-Over-Year; First Half Revenue Increased 15% Year-Over-Year MINNEAPOLIS, MN, August 1, 2022 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for th |
|
| August 1, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R. |
|
| June 23, 2022 |
TCMD / Tactile Systems Technology Inc / MILLENNIUM MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 TACTILE SYSTEMS TECHNOLOGY, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 87357P100 (CUSIP Number) JUNE 17, 2022 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant |
|
| June 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) May 26, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| May 27, 2022 |
Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessi |
|
| May 27, 2022 |
240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.)* (Name of Issuer) Tactile Systems Technology, Inc. (Title of Class of Securities) Common Stock, Par Value |
|
| May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Tactile Systems Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37799 (State or other jurisdiction of incorporation or organization) (Commission File Number) 3701 Wayzata Blvd, Suite 300 Minneapolis, Minnesota 55416 (Address of principal executive offic |
|
| May 10, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (IRS Empl |
|
| May 2, 2022 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS; REAFFIRMS FULL YEAR 2022 OUTLOOK First Quarter Revenue Increased 12% Year-Over-Year MINNEAPOLIS, MN, May 2, 2022 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic di |
|
| May 2, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 T |
|
| May 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 2, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| March 28, 2022 |
DEF 14A 1 tmb-20220509xdef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of th |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? ? Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? ? ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| February 23, 2022 |
Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 23, 2022 |
Exhibit 10.37 Execution Version SECOND AMENDMENT AGREEMENT ? This SECOND AMENDMENT AGREEMENT (this ?Amendment?), dated as of February 22, 2022, is entered into among Tactile Systems Technology, Inc., a Delaware corporation (dba Tactile Medical) (the ?Borrower?), the Lenders (as defined below) signatory hereto, and Wells Fargo Bank, National Association, a national banking association, as administr |
|
| February 23, 2022 |
Offer letter between Eric Pauls and Tactile Systems Technology, Inc. dated April 19, 2021 Exhibit 10.29 ? ? April 19, 2021 ? Tactile Systems Technology ? Tactile Medical 3701 Wayzata Blvd, Suite 300 Minneapolis, MN 55416 612-355-5100 ? Eric Pauls [-] [-] ? Dear Eric: We are pleased to offer you the full-time position as Senior Vice President, Sales at Tactile Medical. Your employment start date is May 1, 2021. This employment offer is conditioned on you countersigning and returning thi |
|
| February 23, 2022 |
Non-Employee Director Compensation Policy ? Exhibit 10.23 ? TACTILE SYSTEMS TECHNOLOGY, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Revised Effective: 01 January 2022 Each non-management director of Tactile Systems Technology, Inc. (the ?Company?) will receive: ? An annual restricted stock unit (RSU) grant on the date of each annual meeting of stockholders at which the director is elected to the board or continues to serve as a directo |
|
| February 23, 2022 |
Offer letter between Kristie Burns and Tactile Systems Technology, Inc. dated February 1, 2021 Exhibit 10.30 ? ? February 1, 2021 ? Tactile Systems Technology ? Tactile Medical 3701 Wayzata Blvd, Suite 300 Minneapolis, MN 55416 612-355-5100 ? Kristie Burns [-] [-] ? ? Dear Kristie: We are pleased to offer you the full-time position as Senior Vice President, Marketing & Clinical Affairs at Tactile Medical. Your start date is March 22, 2021. This employment offer is conditioned on the success |
|
| February 23, 2022 |
Exhibit 4.1 Description of the Registrant?s Securities Registered Under Section 12 of the Securities Exchange Act of 1934 ? ? The following is a summary of the common stock of Tactile Systems Technology, Inc. (?we,? ?us? or ?our?), which is our only class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended. This summary is of the general terms and provision |
|
| February 22, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 18, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| February 22, 2022 |
Tactile Medical Announces Qui Tam Lawsuit Dropped by Plaintiff Exhibit 99.1 Tactile Medical Announces Qui Tam Lawsuit Dropped by Plaintiff MINNEAPOLIS, MN ? February 18, 2022 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD) announced today that the qui tam lawsuit filed by a competitor has been dropped and dismissed by a federal judge in Texas. The lawsuit challenged the propriety of Tactile Medical?s patient and physician education progr |
|
| February 22, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 22, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I |
|
| February 22, 2022 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2022 OUTLOOK Fourth Quarter Revenue Increased 4% Year-Over-Year; Full Year Revenue Increased 11% Year-over-Year MINNEAPOLIS, MN, February 22, 2022 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing med |
|
| February 11, 2022 |
TCMD / Tactile Systems Technology Inc / MACQUARIE GROUP LTD - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Tactile Systems Technology Inc (Name of Issuer) Common Shares (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 11, 2022 |
SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| February 10, 2022 |
TCMD / Tactile Systems Technology Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Tactile Systems Technology Inc. Title of Class of Securities: Common Stock CUSIP Number: 87357P100 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| January 5, 2022 |
Exhibit 99.1 Tactile Medical Announces New Appointments to Board of Directors Appoints Valerie Asbury and Brent Shafer MINNEAPOLIS?January 5, 2022 (GLOBE NEWSWIRE) ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the appoi |
|
| January 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 5, 2022 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S |
|
| November 10, 2021 |
Tactile Systems Technology, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) October 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| November 8, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 8, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I. |
|
| November 8, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-377 |
|
| November 8, 2021 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS; UPDATES FULL YEAR 2021 OUTLOOK Third Quarter Revenue Increased 7% Year-Over-Year; First Nine Months Revenue Increased 14% Year-over-Year MINNEAPOLIS, MN, November 8, 2021 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices |
|
| September 8, 2021 |
Exhibit 10.1 Execution Version FIRST AMENDMENT AGREEMENT This FIRST AMENDMENT AGREEMENT (this ?Amendment?), dated as of September 8, 2021, is entered into among Tactile Systems Technology, Inc., a Delaware corporation (dba Tactile Medical) (the ?Borrower?), the Lenders (as defined below) signatory hereto, and Wells Fargo Bank, National Association, a national banking association, as administrative |
|
| September 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I. |
|
| September 8, 2021 |
Exhibit 2.1 Execution Version ASSET PURCHASE AGREEMENT among TACTILE SYSTEMS TECHNOLOGY, INC., INTERNATIONAL BIOPHYSICS CORPORATION and H. DAVID SHOCKLEY, JR. Dated September 8, 2021 Table of Contents Page Article 1 Terms of the Transactions 1 1.1 Sale and Purchase of Assets 1 1.2 Excluded Assets 3 1.3 Assumed Liabilities 4 1.4 Excluded Liabilities 5 1.5 Assignment of Assets 7 1.6 Purchase Price 7 |
|
| September 8, 2021 |
TACTILE MEDICAL ANNOUNCES ACQUISITION OF AFFLOVEST® Exhibit 99.1 TACTILE MEDICAL ANNOUNCES ACQUISITION OF AFFLOVEST? ? ?????Further expands the Company?s position as a leader in treating patients with underserved chronic conditions in the home ? ????Transaction aligns with Tactile Medical?s growth & margin goals, including 20%+ revenue growth, gross margins above 70% and expanding adjusted EBITDA margins MINNEAPOLIS, MN, September 8, 2021 ? Tactile |
|
| August 2, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| August 2, 2021 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS; UPDATES FULL YEAR 2021 OUTLOOK Second Quarter Revenue Increased 45% Year-Over-Year; First Half Revenue Increased 19% Year-over-Year MINNEAPOLIS, MN, August 2, 2021 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for t |
|
| August 2, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 Ta |
|
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Tactile Systems Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 3701 Wayzata Blvd, Suite 300 Minneapolis, Minne |
|
| May 18, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (IRS Emp |
|
| May 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| May 3, 2021 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS; REAFFIRMS FULL YEAR 2021 OUTLOOK MINNEAPOLIS, MN, May 3, 2021 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the first quarter ended |
|
| May 3, 2021 |
Exhibit 10.1 ? ? ? ? ? ? $25,000,000.00 ? AMENDED AND RESTATED CREDIT AGREEMENT dated as of April 30, 2021, ? by and among ? Tactile Systems Technology, Inc. dba Tactile Medical, as Borrower, ? the Lenders referred to herein, as Lenders, ? and ? WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent and Swingline Lender ? ? ? ? ? ? ? ? Table of Contents Page ARTICLE I DEFINITIONS?1 SECTIO |
|
| May 3, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 T |
|
| April 20, 2021 |
Tactile Medical Appoints Eric Pauls as Senior Vice President of Sales Exhibit 99.1 Tactile Medical Appoints Eric Pauls as Senior Vice President of Sales MINNEAPOLIS—April 20, 2021 (GLOBE NEWSWIRE) —Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Eric Pauls to the position of Senior Vice President of |
|
| April 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S |
|
| April 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? ? Filed by the Registrant ? ? Filed by a Party other than the Registrant ? ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| April 5, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? ? Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? ? ? ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted |
|
| March 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S |
|
| March 12, 2021 |
Amended and Restated By-laws, effective March 10, 2021 Exhibit 3.1 TACTILE SYSTEMS TECHNOLOGY, INC. AMENDED AND RESTATED BY-LAWS Effective: March 10, 2021 Article I OFFICES Section 1.1 REGISTERED OFFICE. The Corporation shall maintain a registered office and registered agent within the State of Delaware at such place within such State as may be designated from time to time by the Board of Directors of the Corporation. Section 1.2 OTHER OFFICES. The Co |
|
| February 24, 2021 |
As filed with the Securities and Exchange Commission on February 24, 2021 Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 23, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2021 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission ( |
|
| February 23, 2021 |
Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 23, 2021 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2021 OUTLOOK Fourth Quarter Revenue Increased 4% Year-Over-Year MINNEAPOLIS, MN, February 23, 2021 ? Tactile Systems Technology, Inc. (?Tactile Medical?) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chroni |
|
| February 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 16, 2021 |
Tactile Systems Technology, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities 8757P100 CUSIP Number December 31, 2020 (Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which th |
|
| February 12, 2021 |
EX-99.2 3 d122146dex992.htm IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY EXHIBIT 2 Ivy Investment Management Company - Tax ID No. 03-0481447 Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940 |
|
| February 12, 2021 |
Tactile Systems Technology, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 3* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 12, 2021 |
to Schedule 13G Joint Filing Agreement EX-99.II Exhibit II to Schedule 13G Joint Filing Agreement The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 12, 2021 in connection with their beneficial ownership of Tactile Systems Technology, Inc. Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is |
|
| February 12, 2021 |
EXHIBIT 1 JOINT FILING AGREEMENT Waddell & Reed Financial, Inc., and Ivy Investment Management Company (the ?Filing Persons?), hereby agree to file jointly a Schedule 13G and any amendments thereto relating to the aggregate ownership by each of the Filing Persons of any voting equity security of a class which is registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, |
|
| February 12, 2021 |
EX-99.I Exhibit I to Schedule 13G Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows: Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. |
|
| February 12, 2021 |
Power of Attorney EXHIBIT 3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, THAT: The undersigned, Waddell & Reed Financial, Inc. |
|
| February 12, 2021 |
SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment #1 Under the Securities and Exchange Act of 1934 Tactile Systems Technology, Inc (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Tactile Systems Technology Inc. Title of Class of Securities: Common Stock CUSIP Number: 87357P100 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Tactile Systems Technology Inc (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| January 5, 2021 |
Tactile Medical Announces Additions to Board of Directors Appointment of Sheri Dodd and Deepti Jain Exhibit 99.1 Tactile Medical Announces Additions to Board of Directors Appointment of Sheri Dodd and Deepti Jain MINNEAPOLIS — January 5, 2021 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Sheri Dodd and Deept |
|
| January 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I. |
|
| November 2, 2020 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS; PROVIDES UPDATED FULL YEAR 2020 OUTLOOK Third Quarter Revenue Decreased 1% Year-Over-Year; Flat Year-Over-Year on an Operational Basis First Nine Months Revenue Decreased 3% Year-over-Year; Flat Year-over-Year on an Operational Basis MINNEAPOLIS, MN, November 2, 2020 – Tactile Systems Technology, Inc. (“Tac |
|
| November 2, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| November 2, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-377 |
|
| September 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R. |
|
| August 3, 2020 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS Second Quarter Revenue Decreased 22% Year-Over-Year; Decreased 20% Year-Over-Year on an Operational Basis First Half Revenue Decreased 5% Year-over-Year; Flat Year-over-Year on an Operational Basis MINNEAPOLIS, MN, August 3, 2020 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medic |
|
| August 3, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37799 Ta |
|
| August 3, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S |
|
| May 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Tactile Systems Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 3701 Wayzata Blvd, Suite 300 Minneapolis, Minne |
|
| May 22, 2020 |
EX-99.1 3 tm2020406d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Tactile Systems Technology, Inc. Announces Appointment of Daniel L. Reuvers as President and Chief Executive Officer MINNEAPOLIS, MN, May 21, 2020 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today anno |
|
| May 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| May 22, 2020 |
Offer letter between Daniel L. Reuvers and Tactile Systems Technology, Inc. dated May 20, 2020 Exhibit 10.1 May 20, 2020 Dear Dan: On behalf of the board of directors of Tactile Systems Technology, Inc., a Delaware corporation (the “Company”), I am very excited to offer you employment as the Company’s President & Chief Executive Officer. We believe that your rich history and expertise will enable you to provide our employees, patients and shareholders with the leadership necessary to contin |
|
| May 7, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (IRS Empl |
|
| May 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. E |
|
| May 4, 2020 |
Exhibit 10.3 TACTILE SYSTEMS TECHNOLOGY, INC. 2016 EQUITY INCENTIVE PLAN Restricted Stock Unit Award Agreement Tactile Systems Technology, Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan (the “Plan”), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreeme |
|
| May 4, 2020 |
EX-10.4 5 tcmd-20200331xex10d4.htm EX-10.4 Exhibit 10.4 TACTILE SYSTEMS TECHNOLOGY, INC. 2016 EQUITY INCENTIVE PLAN Performance Stock Unit Agreement Tactile Systems Technology, Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan (the “Plan”), hereby grants an award of Performance Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in t |
|
| May 4, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37799 T |
|
| May 4, 2020 |
Exhibit 10.1 TACTILE SYSTEMS TECHNOLOGY, INC. Non-Qualified Stock Option Agreement (Executive) Under the 2016 Equity Incentive Plan Tactile Systems Technology, Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s common stock to you, the Participant named below. The terms and conditions of the Option Award are se |
|
| May 4, 2020 |
Exhibit 10.2 TACTILE SYSTEMS TECHNOLOGY, INC. Incentive Stock Option Agreement Under the 2016 Equity Incentive Plan Tactile Systems Technology, Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s common stock to you, the Participant named below. The terms and conditions of the Option Award are set forth in this |
|
| May 4, 2020 |
EX-99.1 2 tcmd-20200504xex99d1.htm EX-99.1 Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS First Quarter Revenue Increased 16% Year-Over-Year; 26% Year-Over-Year on an Operational Basis MINNEAPOLIS, MN, May 4, 2020 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for |
|
| April 17, 2020 |
TCMD / Tactile Systems Technology, Inc DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| April 7, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| April 7, 2020 |
Exhibit 99.1 Tactile Systems Technology, Inc. Reports Preliminary First Quarter 2020 Revenue Results, Withdraws Full Year 2020 Financial Outlook and Provides COVID-19 Business Update Preliminary First Quarter Revenue Increased 14% to 17% Year-Over- Year; 24% to 27% Year-Over-Year on an Operational Basis MINNEAPOLIS, MN, April 6, 2020 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: |
|
| March 19, 2020 |
TCMD / Tactile Systems Technology, Inc DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) ☐ Defin |
|
| March 19, 2020 |
TCMD / Tactile Systems Technology, Inc DEF 14A - - DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| February 27, 2020 |
As filed with the Securities and Exchange Commission on February 27, 2020 As filed with the Securities and Exchange Commission on February 27, 2020 Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 26, 2020 |
EX-99.1 2 ex-99d1.htm EX-99.1 Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS; UPDATES FULL YEAR 2020 FINANCIAL OUTLOOK 2019 Revenue Increased 32% Year-Over-Year; Fourth Quarter Revenue Increased 23% Year-Over-Year MINNEAPOLIS, MN, February 26, 2020 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology |
|
| February 26, 2020 |
Non-Employee Director Compensation Policy Exhibit 10.19 TACTILE SYSTEMS TECHNOLOGY, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Adopted: January 1, 2020 Each non-management director of Tactile Systems Technology, Inc. (the “Company”) will receive: · An annual restricted stock unit (“RSU”) grant on the date of each annual meeting of stockholders at which the director is elected to the board or continues to serve as a director, the numbe |
|
| February 26, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I. |
|
| February 26, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-3779 |
|
| February 26, 2020 |
Exhibit 4.1 Description of the Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934 The following is a summary of the common stock of Tactile Systems Technology, Inc. (“we,” “us” or “our”), which is our only class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended. This summary is of the general terms and provisions of |
|
| February 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Tactile Systems Technology Inc (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| February 14, 2020 |
TCMD / Tactile Systems Technology, Inc / AMERIPRISE FINANCIAL INC - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities and Exchange Act of 1934 Tactile Systems Technology, Inc (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f |
|
| February 14, 2020 |
Identification and Classification of the Subsidiary Which Acquired the Security EXHIBIT 2 Ivy Investment Management Company - Tax ID No. 03-0481447 Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940 |
|
| February 14, 2020 |
Joint Filing Agreement EXHIBIT 1 JOINT FILING AGREEMENT Waddell & Reed Financial, Inc. |
|
| February 14, 2020 |
to Schedule 13G Joint Filing Agreement EX-99.II Exhibit II to Schedule 13G Joint Filing Agreement The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 14, 2020 in connection with their beneficial ownership of Tactile Systems Technology, Inc. Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is |
|
| February 14, 2020 |
Power of Attorney EXHIBIT 3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, THAT: The undersigned, Waddell & Reed Financial, Inc. |
|
| February 14, 2020 |
EX-99.I Exhibit I to Schedule 13G Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows: Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. |
|
| February 14, 2020 |
TCMD / Tactile Systems Technology, Inc / Alger Associates Inc - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 14, 2020 |
Tactile Systems Technology, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 2* Tactile Systems Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 87357P100 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 12, 2020 |
TCMD / Tactile Systems Technology, Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Tactile Systems Technology Inc Title of Class of Securities: Common Stock CUSIP Number: 87357P100 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| January 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2020 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| January 13, 2020 |
EXHIBIT 10.1 Execution Version TRANSITION AND CONSULTING AGREEMENT This Transition and Consulting Agreement (the “Agreement”), dated effective as of January 10, 2020 (the “Effective Date”), is entered into by and between Gerald R. Mattys (“Employee”), and Tactile Systems Technology, Inc., a Delaware corporation (the “Company”). RECITALS WHEREAS, the Company is engaged in the business of developing |
|
| January 13, 2020 |
EXHIBIT 99.1 Tactile Systems Technology, Inc. Reports Preliminary Full Year and Fourth Quarter 2019 Revenue Results; Introduces Full Year 2020 Financial Outlook; Announces CEO Intends to Retire in 2020 2019 Revenue Increased 31% Year-Over-Year; Fourth Quarter Revenue Increased 21% to 22% Year-Over-Year MINNEAPOLIS, MN, January 13, 2020 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq |
|
| November 4, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2019 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R |
|
| November 4, 2019 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS; UPDATES 2019 OUTLOOK Third Quarter Revenue Increased 37% Year-Over-Year; Operating Income Up 134% MINNEAPOLIS, MN, November 4, 2019 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases |
|
| November 4, 2019 |
Exhibit 10.1 Execution Copy THIRD AMENDMENT TO CREDIT AGREEMENT This Third Amendment to Credit Agreement (this “Amendment”) is entered into as of August 2, 2019, by and among (a) Tactile Systems Technology, Inc., a Delaware corporation (dba Tactile Medical) (“Borrower”), (b) the Lenders who are party to this Amendment and the Lenders who may become a party to this Amendment pursuant to the terms o |
|
| November 4, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-3779 |
|
| August 5, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2019 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S |
|
| August 5, 2019 |
Exhibit 99.1 TACTILE SYSTEMS TECHNOLOGY, INC. REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS; UPDATES 2019 OUTLOOK Second Quarter Revenue Increased 32% Year-Over-Year; Operating Income Up 132% MINNEAPOLIS, MN, August 5, 2019 – Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases |
|
| August 5, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37799 Tac |
|
| July 22, 2019 |
Letter Agreement between Tactile Systems Technology, Inc. and Mary Thompson, dated July 16, 2019 Exhibit 10.1 July 16, 2019 Maggie Thompson [****] [****] Dear Maggie: As we’ve discussed, you have requested to retire from full time work, and we have agreed that effective August 1, 2019 (the “Transition Date”) you will cease serving Tactile Systems Technology, Inc. (“Tactile”) as its Senior Vice President, Reimbursement and Payer Relations and will instead begin serving Tactile in the part-time |
|
| July 22, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 16, 2019 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. |
|
| May 24, 2019 |
TCMD / Tactile Systems Technology, Inc SD - - SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Tactile Systems Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 41-1801204 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1331 Tyler Street NE, Suite 200 Minneapolis, Minnesota 55413 (Address of principal |
|
| May 9, 2019 |
Amended and Restated By-laws, effective May 9, 2019 Exhibit 3.3 TACTILE SYSTEMS TECHNOLOGY, INC. AMENDED AND RESTATED BY-LAWS Effective: May 9, 2019 ARTICLE I OFFICES Section 1.1 REGISTERED OFFICE. The Corporation shall maintain a registered office and registered agent within the State of Delaware at such place within such State as may be designated from time to time by the Board of Directors of the Corporation. Section 1.2 OTHER OFFICES. The Corpo |
|
| May 9, 2019 |
Certificate of Amendment to the Certificate of Incorporation, dated May 9, 2019 EX-3.1 2 a19-96641ex3d1.htm EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF TACTILE SYSTEMS TECHNOLOGY, INC. Tactile Systems Technology, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), hereby certifies as follows: FIRST: At a meeting of the Board of Directors of the Corporation, the Board |
|
| May 9, 2019 |
Amended and Restated Certificate of Incorporation, as amended through May 9, 2019 Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TACTILE SYSTEMS TECHNOLOGY, INC. (As Amended Through May 9, 2019) ARTICLE 1 NAME The name of the Corporation is Tactile Systems Technology, Inc. ARTICLE 2 REGISTERED OFFICE The address of the Corporation’s registered office in the State of Delaware is 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808, located in New Castle |
|
| May 9, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2019 TACTILE SYSTEMS TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37799 41-1801204 (State or other jurisdiction of (Commission (I.R.S. E |
